The causes of essential hypertension

British Journal of Clinical Pharmacology

Volumn 42, Issue 1, 1996, Pages 21-27

  Brown, Morris J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Angiotensinogen; Essential hypertension; Genetics

Indexed keywords

ANGIOTENSINOGEN; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

BLOOD PRESSURE REGULATION; CONFERENCE PAPER; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECURRENT DISEASE; SIBLING;

EID: 0029908532     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1996.03785.x     Document Type: Conference Paper

References (16)

1. Postma DS, Bleeckeer ER, Amelung PJ, et al. Genetic susceptibility to asthma - bronchial hyperresponsiveness coinherited with a major gene for atopy. N Engl J Med 1995; 333: 894-900.
2. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease: part I, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765-774.
3. Dickerson JEC, Brown MJ. Influence of age on general practitioners' definition and treatment of hypertension. Br Med J 1995; 310: 574.
4. Risch N, Zhang H. Extreme discordant sib pairs for mapping quantitative trait loci in humans. Science 1995; 268: 1584-1589.
5. Hingorani AD, Jia H, Stevens PA, Hopper R, Dickerson JEC, Brown MJ. Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition. J Hypertension 1995; 13: 1602-1609.
6. Collins R, MacMahon S. Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Br Med Bull 1994; 50: 272-298.
7. Barker DJP, Bull AR, Osmond C, Simmonds SJ. Fetal and placental size and risk of hypertension in adult life. Br Med J 1990; 301: 259-262.
8. Brown MJ, Clayton D. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med (letter) 1994; 331: 1096.
9. Lander ES, Schork NJ. Genetic dissection of complex traits. Science 1994; 265: 2037-2048.
10. Attwood S, Bird R, Burch K, et al. Within-patient correlation between the antihypertensive effects of atenolol, lisinopril and nifedipine. J Hypertension 1994; 12: 1053-1060.
11. Brown MJ, Dickerson JEC. α-blockade and calcium channel blockade: an effective and well tolerated combination for the treatment of resistant hypertension. J Hypertension 1995; 13: 701-707.
12. Lifton RP, Dluhy RG, Powers M. A chimaeric 11 betahydroxylase/aldosterone synthase gene causes glucocorticoid remediable aldosteronism and human hypertension. Nature 1992; 355: 262-265.
13. Stewart PM, Krozowski ZS, Gupta A, et al. Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11b-hydroxysteroid dehydrogenase type 2 gene. Lancet 1996; 347: 88-91.
14. Shimkets RA, Warnock DG, Bositis CM, et al. Liddle's syndrome: heritable human hypertension caused by mutations in the ß-subunit of the epithelial sodium channel. Cell 1994; 79: 407-414.
15. Hansson JH, Nelson WC, Suzuki H, et al. Hypertension caused by a truncated epithelial sodium channel γ subunit: genetic heterogeneity of Liddle syndrome. Nature Genetics 1995; 11: 76-82.
16. Nelson RJ, Demas GE, Huang PL, et al. Behavioural abnormalities in male mice lacking neuronal nitric oxide synthase. Nature 1995; 378: 383-386.